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Abstract: 2D/3D structures resulting from self-assembly of amphiphilic block copolymers can be combined with
bioactive compounds, such as proteins and enzymes, to create supramolecular assemblies with specific desired
properties and functionality. Chemical tuning of the architecture and properties of supramolecular assemblies to
accommodate sensitive biomolecules allows the development of new soft hybrid materials that benefit from the
robustness of polymers and from the functionality of biomolecules. The encapsulation/insertion of biomolecules
(enzymes, mimics, proteins) in self-assembling block copolymer vesicles enables design of ‘nanoreactors’ both
in solutions and at surfaces for highly diverse applications, ranging from production of antibiotics to creation of
artificial organelles. When membrane proteins are inserted into polymer membranes, it is possible to generate
functional membranes or active surfaces with a rapid and specific response. In addition, the selective binding of
ligand-terminated polymers holds potential for targeted delivery of drugs, or for immobilization on solid support,
to provide functional 3D assemblies on an extended surface.
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Introduction
In various domains, including cataly-
sis, medicine, environmental science, and
electronics, new systems are actively being
sought to address the need for stable and
multifunctional membranes for nanome-
ter-scale molecular devices, and for rapid
and sensitive identification of specific
molecules. A smart strategy for develop-
ing such systems consists of combining
synthetic membranes able to mimic bio-
logical membranes with specific biologi-
cal molecules, such as peptides, enzymes
and proteins.
[1]
Such polymer membranes
are generated either as boundaries of 3D
assemblies (capsules, vesicles)or as planar
structures formed on solid supports via po-
lymerization, grafting or spreading.
[2]
Amphiphilic polymers are generally re-
garded as higher molar mass homologues
of lipids. If these polymers contain the
appropriate hydrophobic–hydrophilic do-
mains, they will self-assemble in aqueous
solution to form a variety of supramolecu-
lar assemblies (micelles, vesicles, tubes,
and combinations thereof).
[3]
Amphiphilic
block copolymers frequently form larger
assemblies with considerably higher me-
chanical stability than conventional lipid
bilayers.
[4]
Block copolymers’ properties,
such as hydrophobic/hydrophilic ratio,
molecular mass of each block, and phase
behavior (e.g. fluid or glassy) control the
mechanical stability and flexibility of the
membrane.
[2,5]
Recently the ‘library’ of polymers
that generate membranes mimicking bio-
membranes was considerably extended
with polysaccharides,
[6]
peptides,
[7]
zwit-
terionic
[8]
and stimuli-responsive poly-
mers.
[9]
Symmetric membranes based
on amphiphilic AB and ABA block co-
polymers and asymmetric ones gener-
ated by ABC-type triblock copolymers
have been reported.
[2]
While the synthesis
and self-assembly of ABC triblock co-
polymers such as poly(ethylene oxide)-
block-poly(dimethylsiloxane)-block-poly-
(2-methyloxazoline) (PEO-b-PDMS-b-
PMOXA) have been reported,
[10]
very few
studies contain detailed characterisation
of their morphology.
[11]
Such asymmetric
membranes are of particular interest due to
their ability to undergo membrane inver-
sion, which has significant potential for
novel applications.
[12]
Our group is interested in the develop-
ment of new membrane structures, specifi-
cally spherical compartments and planar
membranes that can accommodate bio-
logical molecules by immobilization at the
surface, by insertion inside the membrane,
and/or by encapsulation in the cavity of 3D
compartments (Fig. 1).
[2]
Fig. 1. A schematic
image of the com-
bination of polymer
membranes (A) with
biomolecules (B). The
polymer membrane
can be a bi- or trilayer
with hydrophilic (blue)
and hydrophobic (red/
yellow) domains, re-
spectively. The shape
of such a membrane
can either be 2D (pla-
nar) or 3D (boundary
of vesicles).
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this requires a particular membrane perme-
ability, which can be induced by using ap-
propriately designed block copolymers
[23]
that form nanoporous membranes, or by
inserting channel proteins into the vesicle
walls (Fig. 2A).
[24]
A variety of nanore-
actors have been reported as a result of
changing the active compounds, and there-
fore the intended applications.
[22–25]
For example,we introduced the concept
of antioxidant nanoreactors to combat re-
active oxygen species, such as superoxide
radicals
[23]
and peroxinitrites,
[26]
which are
well known to be involved in pathologies
associated with oxidative stress. By encap-
sulating superoxide dismutase or its mim-
ics inside the cavity of PMOXA-b-PDMS-
b-PMOXA vesicles, the active compounds
detoxified superoxide radicals in situ.
[23,27]
The in situ detoxification reaction was pos-
sible because of the intrinsic permeability
of PMOXA-b-PDMS-b-PMOXA mem-
brane to superoxide radicals.
By specific selection of hemoglobin,
we successfully designed nanoreactors
with dual functionality: transport of oxy-
gen to serve as artificial blood, and simul-
taneous detoxification of peroxinitrites.
[26]
Indeed, hemoglobin preserved its dual
activity and provided multifunctionality
to the nanoreactors, when encapsulated
in polymer vesicles having a membrane
rendered permeable by insertion of chan-
nel porins, OmpF. The insertion of chan-
nel proteins such as OmpF represents an
elegant approach for the design of nano-
reactors with membrane permeable to
substrates/products, which allows in situ
Here we will present hybrid systems
based on combining bioactive molecules
(enzymes, proteins, mimics) with polymer
membranes that serve as stable boundaries
for nanocompartments and as bilayers on
solid supports. These hybrid systems have
multifunctionality and responsiveness that
help target their use for desired applica-
tions.
Polymer Membranes of
Amphiphilic Copolymers
The versatility of polymer chemistry al-
lows the tailoring of properties and poten-
tial functions of the resulting membranes
in order to support specific applications,
such as targeting approaches in therapeu-
tics, immobilization on solid supports, or
responsive behaviors. The chemical nature
of the basic polymer building blocks has
been exploited for coupling functional
groups, such as peptides and proteins,
[13]
ligands,
[14]
aptamers and antibodies,
[15]
which are suited for molecular recognition
at the surface of vesicles. In recent years,
we and others have successfully applied
molecular recognition interactions for cell
targeting and/or immobilisation of block
copolymer vesicles onto surfaces.
[15,16]
Vesicles of poly(dimethylsiloxane)-
block-poly(2-methyloxazoline) (PDMS-
b-PMOXA) diblock copolymers were
conjugated with trastuzumab antibody
for a fast and specific uptake into SKBR3
cells,
[15]
whilst Ni-NTA groups exposed
at the surface of poly(butadiene)-block-
poly(ethylene glycol) (PB-b-PEG) vesi-
cles served for binding His-tag proteins in
the micromolar range.
[14]
Interestingly, the
distribution of metal-NTA groups on the
surface of vesicles allowed the formation
of a homogeneous biomolecule layer upon
bindingHis-tags or His-tag proteins, due to
a molecular recognition interaction.
A biological molecule is combined
with a polymer membrane by addition to
the system before, during or after the mem-
brane formation.
[17]
Remarkably, synthetic
block copolymer membranes allow a func-
tional insertion of membrane proteins, de-
spite being significantly thicker than lipid
membranes.
[18]
For example, transmem-
brane transport has been demonstrated by
successful incorporation of pore proteins
LamB, OmpF, maltoporin, and aquaporin
into polymer membranes (Fig. 2A).
[2,19]
Such systems offer new possibilities for
bioconversion, filter devices and virus
‘traps’, as has been successfully proved
by development of new highly selective
water-permeable polymer membranes by
inserting the water channel Aquaporin Z
from E. Coli.
[20]
It is interesting tonote that after removal
of the lipid component NADH-ubiquinone
oxidoreductase recovered its activity in
the presence of poly(2-methyloxazoline)-
block-poly(dimethylsiloxane)-block-
poly(2-methyloxazoline) (PMOXA-b-
PDMS-b-PMOXA).
[21]
Polymeric bilayers
having specific molecular properties pro-
vided an environment that allowed mem-
brane proteins to adopt an active confor-
mation. NADH-ubiquinone oxidoreduc-
tase activity served to modulate electron
transfer across the polymermembrane, and
exhibited obvious dependence on the mo-
lecular composition of the block copoly-
mer. This could potentially be exploited for
the design of biomimetic batteries or fuel
cells, or to perform specific chemical reac-
tions inside or across polymer membranes.
Nanoreactors
Recently we introduced the concept
of polymer nanoreactors that use polymer
vesicles with encapsulated active com-
pounds (enzymes, proteins, mimics) as
nanometer-sized reaction compartments
(Fig. 2).
[22]
Polymer compartments play a
dual role with active compounds: to shield
them from the outside environment, for
example, against proteolytic attack, and
to allow them to act in situ. In addition,
the compartments serve to co-encapsulate
different active compounds, in order to
support cascade reactions. To achieve per-
sistent continuous reactions requires selec-
tive permeability of the nanoreactor mem-
brane, in order to exchange substrates and
products with the environment. Typically
Fig. 2. (A) Schematic representation of a nanoreactor based on encapsulation of enzymes and
insertion of channel proteins in their membrane, (B) CLSM image of HeLa cells incubated for 24 h
with artificial peroxisomes (APs) (blue: nucleus stained with Hoechst, green: endosome/lysosome
stained with pH-rodo, red: artificial peroxisomes) (Scale bar = 5 µm), (C) Real time ROS detoxi-
fication kinetics of APs in: a) cells treated with pyocyanin, and b) cells pre-treated with APs (8 h)
followed by treatment with pyocyanin.
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wise synthesis of the polymer with a high
molecular weight and a low polydispersity
index.
[35]
The ‘grafting-from’ approach is
an efficient way to create ‘hydrophilic-
hydrophobic-hydrophilic’ structures,
which resemble biological membranes on
solid supports. However, the dense pack-
ing of the polymer chains reduces the flu-
idity of the resulting membrane, and this
generates steric constraints for protein in-
corporation.
A straightforward way to create planar
membranes on surfaces is the process of
vesicle fusion. For example, well-defined
planarpolymericmembraneswereobtained
using electrostatic interactions between
positively charged poly(2,2-dimethylami-
noethyl methacrylate)-block-poly(n-butyl
methacrylate)-block-poly(2,2-dimethyl-
aminoethyl methacrylate) (PDMAEMA-
b-PBMA-b-PDMAEMA) vesicles and
negatively charged surfaces.
[32a]
The
strength of the vesicle–substrate interac-
tion and the nature of the membranes are
modulated by the surface charge density.
However, the cationic character of the
polymer represents a limitation for techno-
logical applications that require functional
insertion of biologically relevant species,
such as peptides or proteins. The vesicle
fusion approach can also be used for co-
valent immobilization of polymer mem-
branes on solid supports, and the resulting
membranes possess enhanced mechanical
and chemical stability. We have reported
the spreading of sulfur-functionalized
poly(butadiene)-block-poly(ethylene ox-
ide) (PB-b-PEO-LA) vesicles on gold
substrate,
[32c]
but good control of packing
density and surface coverage is not always
feasible.
In order to control the ordering and
packing of molecules, and thereby the
thickness and architecture of the poly-
mer layers, the most suitable preparation
techniques are the Langmuir-Blodgett
(LB) deposition
[36]
and the Langmuir-
enzymatic reactions. Various membrane
proteins such as LamB, FhuA, Tsx, and
AqpZ have been successfully reconsti-
tuted in PMOXA-b-PDMS-b-PMOXA
membranes, and thereby supported the
movement of different molecules (water,
NADH, nucleotides, DNA, enzyme sub-
strates) through the polymeric membrane.
In this respect the functional insertion of
AqpZ in the polymer membrane led to the
production of efficient and sustainable wa-
ter treatment membranes with productivity
at least one order of magnitude higher than
that of the existing salt-rejecting polymer
membranes.
[20]
Such nanoreactors are robust, and effi-
cient for the production of specific drugs in
a desired location, for example in implants.
By encapsulation of the enzyme penicillin
acylase in PMOXA-b-PDMS-b-PMOXA
amphiphilic triblock copolymer, the nano-
reactors serve for local and controlled pro-
duction of antibiotics.
[28]
The amount of
antibiotic produced by the nanoreactors
and then released was able to inhibit bac-
terial growth on agar plates. Because our
system synthesizes an antibiotic on de-
mand, with control of the amount as well
as the timing of synthesis and release, it is
expected to lead to increased therapeutic
efficacy, lower toxic side effects, and re-
duced costs.
A step further in increasing the com-
plexity for specific applications is to co-en-
capsulate active compounds inside nano-
reactors, to support cascade reactions.
[29]
Superoxide dismutase and lactoperoxidase
were shown to participate in sequential
reactions in situ in the nanovesicle cavity,
transforming superoxide radicals to mo-
lecular oxygen and water. The diffusion
of LPO substrate/products was facilitated
by insertion of OmpF.
[29a]
This complex
antioxidant nanoreactor was optimized by
changing the enzymes to superoxide dis-
mutase and catalase in tandem, increasing
the encapsulation efficiency and modula-
tion of membrane permeability. The op-
timized nanoreactor was active for more
than 48 hours after up-take by various cell
lines, thusmimicking peroxisomes, natural
organelle known for their role in detoxifi-
cation of reactive oxygen species (Fig. 2B
and C).
[30]
Such artificial organelles rep-
resent a new concept for cellular implants
able to produce bioactive molecules at a
subcellular level.
Solid-supported Polymer
Membranes
Amphiphilic block copolymers are
suitable for preparing surface-immobilized
membranes, also known as solid-support-
ed polymer membranes. As the membrane
is attached to a solid surface, the resulting
system has improved mechanical stabil-
ity compared to isolated membranes.
[31]
Solid-supported polymer membranes are
similar to solid-supported lipidmembranes
in architecture and fluidity, but outperform
them in thickness and stability. A variety
of strategies are available for immobi-
lizing polymer membranes on surfaces:
synthetic methods (grafting-to, grafting-
from), fusion of vesicles on solid supports,
and transfer of monolayers. They can be
advantageously combined with membrane
modifications or the insertion/attachment
of active compounds to generate highly
‘active surfaces’.
[2]
The most common
architectures for solid-supported polymer
membranes are: i) surface immobilized
planar membranes (Fig. 3A),
[32]
and ii)
surface-tethered vesicles (Fig. 3B).
[33]
The ‘grafting-to’ technique for prepa-
ration of polymer solid-supported mem-
branes consists of anchoring previously
synthesized polymers to a substrate via
chemical or physical interactions.
[34]
The
major drawback of the ‘grafting-to’ meth-
od is the lack of full surface coverage due
to excluded volume effects of the polymer
chains on the surface, and uncontrollable
orientation of the chains during the an-
choring procedure. Whilst experimentally
simple, samples prepared using this ap-
proach are frequently not reproducible.
[35]
To overcome this disadvantage, the ‘graft-
ing-from’ method involves a covalent im-
mobilization of small initiator molecules
on the surface, followed by step-by-step
polymerization to obtain a membrane with
defined architecture. The first successful
attempt using this approach was the cova-
lent immobilization of the poly(2-hydroxy-
ethyl methacrylate)-block-poly(n-butyl
methacrylate)-block-poly(2-hydroxyethyl
methacrylate) (PHEMA-b-PBMA-b-
PHEMA) membrane on gold and silicon
solid supports by using surface-initiated
atom transfer radical polymerization
(ATRP). ATRP allows a controlled step-
Fig. 3. Scheme for the two most common configurations for solid-supported polymer mem-
branes, (A) surface immobilized planar membranes, which are able to be prepared by graph-to/
graph-from, vesicle fusion or monolayer transfer method, and (B) surface tethered vesicles. Planar
membranes can be prepared by the surface grafting method, vesicle fusion, and monolayer trans-
fer methods.
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Schaefer (LS) deposition.
[37]
Recently,
we assembled – for the first time – two
polymer layers to serve as solid-supported
biomimetic membranes.
[32b]
A defect-free,
homogeneous film of PB-b-PEO-LA was
formed and immobilized on gold substrate
by LB deposition, and this served as an
anchoring layer on the solid support. A
second layer of hydroxyl-functionalized
poly(butadiene)-block-poly(ethylene ox-
ide) (PB-b-PEO-OH) was then deposited
by LS transfer; its attachment is mainly
governed by hydrophobic interactions be-
tween the poly(butadiene) (PB) blocks.
The assembled bilayers were uniform, flu-
id and defect-free, with a typically hydro-
philic-hydrophobic-hydrophilic structure,
and a thickness of 11 nm.
Apart from planar solid-supported
membranes, a tethering concept is used
to immobilize vesicles on solid surfaces.
Tethered vesicles represent ideal candi-
dates for applications such as chemical/
biological reactions with precise control
of the reaction environment,
[38]
and en-
capsulation of active compounds in very
small volumes for studies down to the
single-molecule level.
[39]
The drawbacks
of relatively high permeability and fragil-
ity of liposomes immobilized on solid sub-
strates have been overcome by using stable
polymeric vesicles.
[40]
To support the tethering concept vari-
ous interactions have been used, such as
DNA hybridization,
[41]
or biotin-strepta-
vidin interaction.
[38]
The modification of
block copolymer membranes with specific
recognition sites represents an elegant way
for surface immobilization. Appropriately
designed surface membranes, which con-
tain molecules involved in biological rec-
ognition interactions, offer considerable
potential for: i) fundamental investigations
of this type of interaction, ii) as platforms
to bind and sense the presence of specific
molecules (proteins, enzymes, DNA), and
iii) to create new materials where this type
of interaction serves as a link between two
different assemblies. For example, pro-
tein binding to metal–NTA functionalized
block copolymer membranes on a solid
support induces the formation of densely
packed and ordered protein arrays that
open a new route to induce 2D crystalliza-
tion of proteins or to develop new types of
biosensors.
[42]
By designing two different
polymersome–antibody conjugates using
either anti-biotin IgG or trastuzumab, it
was possible to specifically target biotin-
patterned surfaces, which is an approach
that appears promising for the develop-
ment of new diagnostic materials.
[15]
Surface-tethered polymer vesicles con-
taining active compounds (e.g. enzymes,
proteins, mimics) in their aqueous cavities
allow the development of precise local-
ized nanoreactors, which are essential for
medical applications, such as in implants
or for patches. The first example of immo-
bilized nanoreactors was introduced by an
enzymatic reaction of acid phosphatase en-
capsulated in poly(2-methyl-2-oxazoline)-
block-poly(dimethylsiloxane)-block-
poly(2-methyl-2-oxazoline) vesicles that
had been immobilized on a solid support
via streptavidin-biotin interactions. OmpF
inserted in the polymer membrane allowed
the penetration of the substrate ELF97 to
the inside of the nanoreactor and to support
the acid phosphatase reaction in situ (Fig.
4B).
[33]
This system provided a first direct
comparison between the activity of an en-
capsulated enzyme and that of the enzyme
in free conditions.
Compared with solid-supported lipid
membranes (with a hydrophilic/water lay-
er of 1–3 nm),
[43]
the thickness of polymer
membranes ranges from 3 up to 40 nm, de-
pending on the hydrophilic and hydropho-
bic polymer blocks. These higher values of
membrane thickness have the advantage of
preventing strong interactions and/or fric-
tional coupling between the solid substrate
and incorporated proteins, which could re-
sult in partial loss of functionality or com-
plete protein denaturation.
[44]
By application of the Langmuir mono-
layer technique, it is possible to control
the membrane film properties at the air–
water interface, which is essential for
studies of membrane protein insertion in
a synthetic environment. For example,
the miscibility (or phase separation) be-
havior of binary monolayers of PMOXA-
PDMS-PMOXA triblock copolymers and
the antimicrobial peptide alamethicin,
was investigated to find favorable condi-
tions for insertion, and to obtain greater
insight into the insertion process itself.
[45]
Compared to lipid membranes, the larger
polymer membrane possesses more flex-
ibility and is able to adopt more conforma-
tions, and thus to support the hosting of a
wider range of biomolecules in the mem-
brane. Alternatively, mixed phase separat-
ed polymer–lipid thin films represent an
interesting platform for more controlled
and predictable location of membrane
proteins.
[46]
Interactions of poly(ethylene
oxide)-block-poly(propylene oxide)-
block-poly(ethylene oxide) (PEO-b-PPO-
b-PEO) with various phospholipids
[47]
and cell membrane have been studied.
[48]
Interestingly, the bacterial porin OmpF
[46]
was found to be mainly present in the poly-
mer-rich phase of the films based on mix-
tures of the PMOXA-b-PDMS-b-PMOXA
triblock copolymer and 1,2-dipalmitoyl-
sn-glycero-3-phosphocholine.
Although the stronger interactions be-
tween polymer layers and substrates limit
the mobility of polymers in solid-support-
ed polymer bilayer membranes, the non-
covalent interactions between two polymer
layers allows a certain degree of membrane
fluidity. This fluidity is essential for the in-
sertion of peptides andmembrane proteins,
as we have established for insertion of the
peptide, polymyxin B. However, polymyx-
in B did not form a transmembrane pore,
but instead interacted with the polymer
membrane in a detergent-like manner by
creating transient defects and partly disas-
sembling the membrane.
[32c]
Very recently, we reported the first
functional incorporation of a water-solu-
ble polypeptide, alpha-haemolysin in an
artificial polymer tethered solid-supported
bilayer membrane, TSSBM (Fig. 4A).
[49]
The conductance variation upon chan-
nel protein insertion was modelled with
Donnan potential, indicating that ions ac-
cumulated in the inner, hydrophobic part
of the polymer membrane. Preliminary
results indicated that the membrane pro-
tein OmpF was also functionally inserted,
although in this case the presence of de-
tergents was necessary. By substitution of
one membrane protein by another, it will
be possible to understand functional chan-
nel protein insertion, or to develop novel
applications, such as biosensing, drug
screening, or trace compound analysis.
Improvements of solid-supported poly-
mer membrane systems can be achieved by
forming pore-solid-supported membranes
on porous pattern substrates. Such pore-
solid-supported membranes can probe the
functionality of different transmembrane
proteins (Fig. 4C), and are particularly
attractive because they combine the me-
chanical stability of solid-supported mem-
branes with the advantage of free-standing
membranes. In addition, they offer unprec-
edented mechanical stability over periods
of dayswithmesh sizes between 20 nm and
several micrometers, in defined geometric
patterns. A pore-solid-supported polymer
membrane embedded with channel porin
Aquaporin (AqpZ) has served to generate
a highly permeable membrane that allows
Fig. 4. Schemes of
membrane consti-
tuted (A) solid-sup-
ported planar mem-
branes, (B) surface
tethered vesicles and
(C) pore-solid-sup-
ported membranes.
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passive diffusion of small solutes such as
ions, nutrients, or antibiotics.
[50]
Moreover,
high density reconstitution of functional
AqpZ in a planar polymer membrane is
achievable.
[51]
Conclusions
Amphiphilic copolymers, which self-
assemble into supramolecular structures,
represent ideal candidates for forming 2D
and 3Dassemblies that can contain biomol-
ecules or combinations thereof, because
their chemistry allows the adjustment of
properties such as stability, flexibility, and
functionality. Up to now, most of the stud-
ies available on protein or peptide insertion
into polymer membranes have been per-
formed on vesicular systems, free-standing
membranes, or monolayers at the air/water
interface. Only recently, solid-supported
polymer membranes have been introduced
as templates for biomolecules to create
‘active surfaces’, which are particularly
interesting for prospective technological
applications, such as sensing, which may
require the functional incorporation of pro-
teins or peptides into the solid-supported
polymer membranes.
Although there are many reported com-
binations of biomolecules with polymer
membranes, there are still open questions
to be solved because this is an emerging
field. The reported systems are of interest
from the fundamental point of view, and
require further developments in terms of
stability and functionality for potential ap-
plications.
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